what are the main cryptocurrencies Top searches

Xie Yunliang, macro chief analyst of Cinda Securities, said that historically, the establishment of a "moderately loose" policy orientation needs to meet two major conditions, namely, the domestic pressure to stabilize prices is high and the foreign Federal Reserve is in a loose cycle. At present, it is judged that both situations may exist next year.Kei Ma quit Xiaomi Home Technology Co., Ltd., and Tianyancha App showed that recently, Xiaomi Home Technology Co., Ltd. underwent industrial and commercial changes, and Kei Ma stepped down as the legal representative and manager. As Peng took over, Lei Jun was changed from an executive director to a director. Xiaomi Home Technology Co., Ltd. was established in January 2017 with a registered capital of RMB 80 million. Its business scope includes communication equipment sales, computer software and hardware and auxiliary equipment wholesale, computer software and hardware and auxiliary equipment retail, shoes and hats wholesale, motorcycles and spare parts wholesale, etc. It is wholly owned by Xiaomi Communication Technology Co., Ltd. According to media reports, recently, Kei Ma, vice president of Xiaomi Group, has left his post, and the news has aroused many concerns.*ST Hanma: The reorganization plan of the company and its five subsidiaries was approved by the court. On December 11, 2024, the company and its five subsidiaries, Anhui Valin Automobile Co., Ltd., Anhui Xingma Special Purpose Vehicle Co., Ltd., Anhui Fuma Automobile Parts Group Co., Ltd., Anhui Fuma Electronic Technology Co., Ltd. and Wuhu Fuma Automobile Parts Co., Ltd., received the court ruling, approved their reorganization plans and terminated the reorganization procedures, and then entered the implementation stage.

Eight-day four-board three-dimensional communication: the company's operation is normal, and the internal and external operating environment has not changed significantly. On December 9, December 10 and December 11, 2024, the company's closing price increase deviated by more than 20% for three consecutive trading days, which belongs to the abnormal fluctuation of stock trading. The company's operation is normal, and the internal and external operating environment has not changed significantly. The Company has no other circumstances that violate the provisions on fair disclosure of information.ZTE signed a strategic cooperation agreement with Daiyu and Midea Group. Recently, ZTE signed a strategic cooperation agreement with Daiyu and Midea Group in Chengdu. In the future, the two sides will carry out in-depth cooperation in VR space, AR application and MR interaction.After the strike ended, the delivery of Boeing aircraft dropped to 13 in November. On Tuesday, Boeing reported that it delivered 13 commercial jets in November, less than a quarter of the 56 jets delivered to customers 12 months ago. The number of deliveries in October decreased from 14 in October, when most of the company's aircraft production was still in a state of suspension, and 33,000 factory workers went on strike for seven weeks, which ended on November 5. Boeing shares closed up 4.5% on Tuesday. The aircraft manufacturer said that after weeks of methodical preparations, the company restarted the production of the 737 MAX and loaded the new fuselage into the Renton factory in Seattle.

Sources: The attack on the Russian oil depot did not affect the oil transportation to Europe via Ukraine. Ukrainian industrial sources said on Wednesday that the Ukrainian attack on an oil depot in the Bryansk region of Russia at night did not affect the oil transportation to Europe via Ukraine. The Ukrainian military said on Wednesday that the warehouse was part of the "Friendship" oil export pipeline and a "fire" broke out after the air raid. The source said: "This attack has nothing to do with oil transportation because it is a facility to ensure the supply of diesel and petroleum products. Everything is going according to plan. "Market information: Honda will terminate its autonomous driving partnership with General Motors.Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.